In this free webinar, gain insight into how integrated custom media development and manufacturing can reduce risk from non-GMP to GMP. Attendees will learn ways to align early prototyping with ...

If Good Manufacturing Practice (GMP) guidelines feel more like a maze of regulations than a roadmap to action, you’re not alone. Many professionals struggle to translate GMP requirements into clear, ...

Dublin, April 29, 2026 (GLOBE NEWSWIRE)-- The "GMP Auditing for FDA-Regulated Industries: A Practical Guide (July 6th - July 7th, 2026)" training has been added to ResearchAndMarkets.com's offering.

CRISPR-Cas9 is one of the most commonly leveraged non-viral editing tools to engineer cells for therapeutics applications. It is a nuclease-based genome editing system which has seen exponential ...

Over the last few years, RNA-encapsulated lipid nanoparticles (RNA-LNPs) have emerged as a new drug modality with the potential to change the pace of biopharmaceutical innovation. GMP manufacturing of ...

A future of long-term, minimally toxic immunotherapy personalized to the cellular level is on the horizon—but only if manufacturers have the means to produce these therapies within a GMP environment.

Stem cell therapies are beginning to enter the clinic, and their quality and safety depends on raw materials (ancillary reagents) used in their production. With the clinical phases of development of a ...

In drug manufacturing, aseptic filling is the crucial final step in advancing biologics candidates into the clinic. Whether drug manufacturers outsource the process to a CDMO or bring the filling ...